Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Parkinson's Disease

  Free Subscription

Articles published in PLoS Comput Biol

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    August 2021
  1. WEERASINGHE G, Duchet B, Bick C, Bogacz R, et al
    Optimal closed-loop deep brain stimulation using multiple independently controlled contacts.
    PLoS Comput Biol. 2021;17:e1009281.
    PubMed     Abstract available

    July 2021
  2. DUCHET B, Ghezzi F, Weerasinghe G, Tinkhauser G, et al
    Average beta burst duration profiles provide a signature of dynamical changes between the ON and OFF medication states in Parkinson's disease.
    PLoS Comput Biol. 2021;17:e1009116.
    PubMed     Abstract available

    March 2021
  3. STAMATE C, Saez Pons J, Weston D, Roussos G, et al
    PDKit: A data science toolkit for the digital assessment of Parkinson's Disease.
    PLoS Comput Biol. 2021;17:e1008833.
    PubMed     Abstract available

  4. WANG M, Hou S, Wei Y, Li D, et al
    Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking.
    PLoS Comput Biol. 2021;17:e1008821.
    PubMed     Abstract available

    December 2020
  5. FARDET T, Levina A
    Simple models including energy and spike constraints reproduce complex activity patterns and metabolic disruptions.
    PLoS Comput Biol. 2020;16:e1008503.
    PubMed     Abstract available

    March 2020
  6. BAHUGUNA J, Sahasranamam A, Kumar A
    Uncoupling the roles of firing rates and spike bursts in shaping the STN-GPe beta band oscillations.
    PLoS Comput Biol. 2020;16:e1007748.
    PubMed     Abstract available

    August 2019
  7. WEERASINGHE G, Duchet B, Cagnan H, Brown P, et al
    Predicting the effects of deep brain stimulation using a reduced coupled oscillator model.
    PLoS Comput Biol. 2019;15:e1006575.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.